From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Outcome | Intervention area | ||||
---|---|---|---|---|---|
 | No intervention | Outreach | VMW | ||
 | % (n) | % (n) | AOR (95% CI) | % (n) | AOR (95% CI) |
Received biological diagnosis | 17% (42/251) | 35% (31/88) | 2.4 (0.6–8.9) (p = 0.102) | 63% (14/22) | 10.7 (4.7–24.3) (p =< 0.001) |
Received modern drugs | 85% (213/251) | 84% (74/88) | 0.7 (0.3–1.5) (p = 0.340) | 63% (14/22) | 0.28 (0.1–0.8) (p = 0.03) |
Received drugs from trained provider (of those who received modern drugs) | 8% (17/206**) | 31% (23/74) | 4.0 (1.2–13.2) (p = 0.023) | 93% (13/14) | 147.5 (8.5–2571) (p = 0.002) |
Received artesunate and mefloquine (of those who received modern drugs) | 8% (17/210**) | 22% (16/74) | 2.7 (1.0–7.6) (p = 0.053) | 64% (9/14) | 7.7 (1.8–28.2) (p = 0.007) |
Paid > $1 for treatment (of those who received modern drugs) | 52% (110/210**) | 46% (34/74) | 1.2 (0.6–2.1) (p = 0.525) | 29% (4/14) | 0.55 (0.2–1.9) (p = 0.107) |